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Miniaturized Experimental Toolbox for  
ω-Transaminase Technology (BIOINTENSE) 
Introduction:  
The next generation biocatalytic processes in industry face new challenges, e.g. high 
concentration operation, unfavourable reaction equilibrium, complex molecule for-
mation, minimum environmental impact, etc. [1].  Significant work is therefore re-
quired for development of the biocatalyst and process to fit commercial requirements. 
It is quite demanding to find the best biocatalyst and process combination to fit indus-
trial requirements, especially with respect to the limited resource availability at an ear-
ly stage of development. 
BIOINTENSE, an EC FP7 funded program, has focus on developing toolboxes capable of 
accelerating biocatalyst and process development through the use of modular mi-
crosystem platforms.  Operation at micro-scale enable better process control, low con-
sumption of resources, fast process evaluation, as well as rapid mass and heat transfer 
[2, 3]. 
BIOINTENSE will deliver 3 types of platforms (figure 1): 1) High data content biocatalyst 
The quality of models is to a large extent determined 
by the number of experimental data points available 
(Figure 2). Conventional analytics require certain sam-
ple quantities, limiting the number of samples that 
can be collected. Micro-scale operations can offer so-
lutions to these requirements.  
Platform 1 
As a result of the theoretical process design unit oper-
ations (MUO’s—Miniaturized Unit Operations) are 
chosen for data collection, constrained by economic 
assessment. The collected data will provide hard con-
straints for the biocatalyst performance. 
 
Platform  2 
The target from platform 1 will be reached by devel-
opment of the biocatalyst through protein engineer-
ing. The mutants will be evaluated by high content 
screening methods. 
 
Platform 3 
By combining the process design and developed bio-
catalysts, system validation  of the production 
platforms is performed by synthesis of the product-in-
the-bottle as final evaluation.  
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screening platforms, 2) generic process development platforms operated by the 
plug-and-play principle, 3) production platforms for product synthesis.  
The platforms will be developed for ω-transaminase-catalysed reaction systems, 
scheme 1. These systems are quite interesting due to the highly unfavourable 
equilibrium of such reactions and the severe inhibiting effects of both substrates 
and products, although there are also systems enabling complete conversion.  
 [4, 5, 6, 7]. 
 
Scheme 1: Example of reaction scheme from benzylacetone to (S)-3-amino-1-phenylbutane      
 
 
 
Different amine donors: alanine, isopropylamine, and methylbenzylamine 
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